Michael Lichtenberg: Long-Term Results of Venovo Venous Stenting From the Arnsberg Venous Registry
Michael Lichtenberg, Chief Physician Arnsberg Vascular Center, Arnsberg, Germany, shareda post on LinkedIn:
“At the VEITHsymposium in New York, I presented eight year follow up data on iliofemoral venous stenting from our Arnsberg Venous Registry.
Our center in Arnsberg performs more than 300 venous interventions annually.
Eight year primary patency with the Venovo venous stent was 91.8 percent overall, with 93.5 percent in patients with non thrombotic iliac vein lesions and 90.7 percent in those with post thrombotic syndrome.
Pain scores and CEAP clinical class improved from baseline, and no stent fractures were observed.
Thank you to our patients and the Arnsberg vascular team for making this long term follow up possible.”
Stay updated with Hemostasis Today.
-
Nov 21, 2026, 06:24Platelets Journal: Glycocalicin Accumulation Within Thrombi Reveals Species-Specific Mechanisms
-
Nov 21, 2026, 03:45Aref Ghanaatpisheh: The Role of Systemic Inflammation in Preoperative Deep Vein Thrombosis Risk Assessment
-
Nov 21, 2026, 03:43Dimitrios Hatzichristou: Advancing Standardization and Quality Control in Platelet-Rich Plasma Therapy
-
Nov 21, 2026, 03:15Amirabbas Sheykhalo: Silent Mesenteric Ischemia in Portomesenteric Thrombosis
-
Nov 21, 2026, 02:51Ivone Su: Raising Awareness of Venous Thromboembolism
-
Nov 21, 2026, 02:40Aniqa Gohar: One Heart Conclave – Advancing Integrated Thrombosis Care
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon